Skip to main content
. 2018 Jan 27;391(10118):329–338. doi: 10.1016/S0140-6736(17)32457-1

Table 1.

Baseline characteristics of the intention-to-treat population

Decompression (n=106) Arthroscopy only (n=103) No treatment (n=104)
Female 54 (51%) 52 (50%) 52 (50%)
Age 52·9 (10·3) 53·7 (10·5) 53·2 (10·2)
Previously received injections in study shoulder 2 (1–3) for n=105 2 (1–3) 2 (1–3)
Oxford Shoulder Score 25·2 (8·5) 26·7 (8·8) 25·5 (8·3)
Modified Constant-Murley Score 39·4 (13·9), n=102 43·1 (15·5), n=101 38·3 (14·2), n=100
PainDETECT Score 11·7 (6·6), n=105 11·0 (5·9) 11·9 (6·6), n=100
HADS Depression Score 5·0 (3·8), n=105 5·0 (3·7), n=102 5·7 (4·2)
HADS Anxiety Score 6·3 (4·3) 6·3 (4·2) 6·9 (4·5)
EQ VAS 65·8 (19·4) 69·7 (19·2) 64·4 (23·2)
EQ-5D-3L Index 0·52 (0·30), n=105 0·55 (0·29), n=102 0·50 (0·33)

Data are n (%), mean (SD), or median (IQR). Oxford Shoulder Score range 0 to 48. Modified Constant-Murley Score range 0 to 100. PainDETECT score −1 to 38. Hospital Anxiety and Depression Scale (HADS) Depression and Anxiety Score range 0 to 21. EuroQol 5 dimensions 3 level index (EQ-5D-3L) range −0·59 to 1·0. EuroQol visual analogue scale (EQ VAS) range 0–100. A higher score indicates a better state for all measures except for HADS and PainDETECT.